Hafrun Fridriksdottir - 04 Mar 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for Hafrun Fridriksdottir
Issuer symbol
TEVA
Transactions as of
04 Mar 2022
Net transactions value
-$250,219
Form type
4
Filing time
08 Mar 2022, 15:07:49 UTC
Previous filing
02 Mar 2022
Next filing
19 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +51,488 +79% 116,997 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $134,835 -18,020 -15% $7.48 98,977 04 Mar 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +18,905 +19% 117,882 04 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $49,519 -6,618 -5.6% $7.48 111,264 04 Mar 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +23,764 +21% 135,028 05 Mar 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale $65,866 -8,941 -6.6% $7.37 126,087 07 Mar 2022 Direct F1, F3, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -51,488 -100% $0.000000* 0 04 Mar 2022 Ordinary Shares 51,488 Direct F1, F2, F7
transaction TEVA Restricted Share Units Options Exercise $0 -18,905 -50% $0.000000 18,906 04 Mar 2022 Ordinary Shares 18,905 Direct F1, F2, F8
transaction TEVA Restricted Share Units Award $0 +140,750 $0.000000 140,750 04 Mar 2022 Ordinary Shares 140,750 Direct F1, F2, F9
transaction TEVA Restricted Share Units Options Exercise $0 -23,764 -25% $0.000000 71,293 05 Mar 2022 Ordinary Shares 23,764 Direct F1, F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F8 Restricted share units were granted on March 4, 2019, with 18,905 having vested on each of March 4, 2021 and March 4, 2022, and 18,906 vesting on March 4, 2023.
F9 Restricted share units were granted on March 4, 2022, with 35,187 vesting on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 35,189 vesting on March 4, 2026.
F10 Restricted share units were granted on March 5, 2021, with 23,764 having vested on March 5, 2022, 23,764 vesting on each of March 5, 2023 and March 5, 2024, and 23,765 vesting on March 5, 2025.